HHS and the White House are involved in policy discussions regarding generic drugs, including potential agreements concerning U.S. tariffs and the tardive dyskinesia market.

The entities involved

• Department of Health & Human Services →

  government department in the state of Victoria, Australia

  • The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02
  • The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.Mon 12:10
• White House →
  • Demands for lower interest rates are being followed, complicated by the current labor market rebound.Mon 15:27
  • The New York Times reported on specific actions taken by the Trump Administration.Mon 15:10
• Neurocrine Biosciences →

  American biopharmaceutical company

  Nothing else this week.

Related events

• Sun Pharmaceutical Industries agreed to lower US drug prices in exchange for tariff concessions from the US government.Sep 1